The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Biopharmaceutical Excipients Market Progress Between 2026 And 2030?
The biopharmaceutical excipients market has demonstrated robust expansion over recent years. Its valuation is expected to rise from $3.27 billion in 2025 to $3.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historical growth can be attributed to several factors including a rise in biologic drug approvals, the early implementation of protein stabilizers, an increase in injectable formulations, the broader development of vaccines, and progress in formulation science.
The biopharmaceutical excipients market is poised for robust expansion in the coming years. It is projected to achieve a value of $5.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This anticipated growth can be attributed to several factors, including the increasing intricacy of biologic formulations, a surging demand for products with extended shelf lives, the ongoing expansion of cell and gene therapies, an intensifying regulatory focus on excipient safety, and increased investments in sophisticated drug delivery systems. Key trends anticipated within this period include a heightened demand for high-purity biologic excipients, a growing utilization of multifunctional formulation ingredients, the broadening application of excipients for cell and gene therapies, an increased emphasis on stability-enhancing compounds, and greater customization of excipient solutions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp
Which Major Drivers Are Influencing The Expansion Of The Biopharmaceutical Excipients Market?
The expanding need for vaccine creation is projected to drive the future expansion of the biopharmaceutical excipients market. Vaccine creation involves the method of designing and preparing immunizations aimed at preventing infectious illnesses and enhancing public health, with a dependence on superior excipients to guarantee the stability, effectiveness, and safety of the final vaccine products. This rising requirement for vaccine development originates from a worldwide emphasis on preventing infectious diseases, enhancing readiness in public health, and speeding up research to provide more rapid and potent immunization solutions. Within vaccine formulations, biopharmaceutical excipients perform an essential function by stabilizing antigens, improving solubility, and preserving integrity during storage and distribution. For example, data from 2025, provided by the Centers for Disease Control and Prevention, a US-based national public health agency, indicates that adolescent vaccination rates for important vaccines such as tetanus, diphtheria, and acellular pertussis climbed from 89.9% in 2022 to 91.3% in 2024. Meningococcal conjugate vaccine coverage also saw an increase from 88.6% to 90.1%; and human papillomavirus vaccine coverage (=2 doses) expanded considerably from 76.0% to 92.6% during this identical timeframe. Consequently, the escalating demand for vaccine development is fueling the growth of the biopharmaceutical excipients market.
How Are Different Segments Classified In The Biopharmaceutical Excipients Market Segment Analysis?
The biopharmaceutical excipients market covered in this report is segmented –
1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents
2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics
3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives
4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy
5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes
Subsegments:
1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders
2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings
3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol
4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate
5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide
6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol
7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols
8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate
9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers
Which Trends Are Contributing To Changes In The Biopharmaceutical Excipients Market?
Key players within the biopharmaceutical excipients sector are increasingly emphasizing technological advancements, including ultra-high purity surfactants, to enhance protein stability, mitigate degradation, and ensure adherence to regulatory standards for injectable products. These surfactants represent highly refined surface-active compounds, characterized by extremely low impurity levels and a uniform makeup, specifically developed to guarantee stability, safety, and optimal performance in delicate pharmaceutical and biopharmaceutical preparations. An example of this innovation is the launch of MaxiPure Polysorbate 80 by Evonik Industries AG, a German chemicals company, in September 2025, targeting injectable and biopharmaceutical applications. This particular excipient is formulated with an oleic acid concentration surpassing ninety-eight percent, boasts remarkable clarity, and fully conforms to the rigorous standards set by the European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia. Its capabilities include tackling crucial issues in protein stability, inhibiting oxidative breakdown, facilitating the consistent solubilization of hydrophobic active pharmaceutical ingredients, and bolstering overall formulation reliability. The incorporation of this excipient allows Evonik to support pharmaceutical and biopharmaceutical companies in the efficient development of intricate biologics and injectable therapies, simultaneously guaranteeing both safety and regulatory adherence.
Who Are The Companies Driving Activity In The Biopharmaceutical Excipients Market?
Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.
Get The Full Biopharmaceutical Excipients Market Report:
https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report
Which Region Accounts For The Largest Portion Of The Biopharmaceutical Excipients Market?
North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biopharmaceutical Excipients Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report
Browse Through More Reports Similar to the Global Biopharmaceutical Excipients Market 2026, By The Business Research Company
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Organic Pharmaceutical Excipients Market Report 2026
Nutraceutical Excipients Market Report 2026
https://www.thebusinessresearchcompany.com/report/nutraceutical-excipients-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model